Foghorn Therapeutics Inc. Capital Expenditures
Foghorn Therapeutics Inc. (FHTX) reported Capital Expenditures of $50.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $50.00K, a 127.27% increase year-over-year.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $50.00K, a 94.48% decline from fiscal 2024.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $906.00K, a 25.98% decline from fiscal 2023.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.22M, a 1.16% increase from fiscal 2022.
- Foghorn Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.21M, a 63.48% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $50.00K 10-Q · filed 2026-08-06 | $50.00K derived: sum of 3 quarters · filed 2026-08-06 | $50.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $22.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $22.00K derived: sum of 3 quarters · filed 2026-08-06 | $50.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $22.00K derived: sum of 2 quarters · filed 2026-08-06 | $50.00K 10-Q · filed 2025-11-05 | $529.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $50.00K 10-Q · filed 2026-08-06 | $529.00K derived: sum of 3 quarters · filed 2026-08-06 | $838.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $28.00K 10-Q · filed 2026-05-07 | $507.00K derived: sum of 2 quarters · filed 2026-05-07 | $816.00K derived: sum of 3 quarters · filed 2026-05-07 | $833.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $788.00K derived: sum of 2 quarters · filed 2026-03-11 | $805.00K derived: sum of 3 quarters · filed 2026-03-11 | $906.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $326.00K derived: sum of 2 quarters · filed 2025-11-05 | $427.00K 10-Q · filed 2025-11-05 | $464.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $118.00K 10-Q · filed 2025-08-05 | $155.00K derived: sum of 3 quarters · filed 2025-08-05 | $237.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $101.00K 10-Q · filed 2025-05-14 | $138.00K derived: sum of 2 quarters · filed 2025-05-14 | $220.00K derived: sum of 3 quarters · filed 2025-05-14 | $689.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $119.00K derived: sum of 2 quarters · filed 2025-03-06 | $588.00K derived: sum of 3 quarters · filed 2025-03-06 | $1.22M 10-K · filed 2025-03-06 |
| 2023-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $551.00K derived: sum of 2 quarters · filed 2024-11-04 | $1.19M 10-Q · filed 2024-11-04 | $1.46M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.10M 10-Q · filed 2024-08-08 | $1.37M derived: sum of 3 quarters · filed 2024-08-08 | $1.70M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $636.00K 10-Q · filed 2024-05-06 | $905.00K derived: sum of 2 quarters · filed 2024-05-06 | $1.24M derived: sum of 3 quarters · filed 2024-05-06 | $1.60M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $599.00K derived: sum of 2 quarters · filed 2024-03-07 | $963.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.21M 10-K · filed 2024-03-07 |
| 2022-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $694.00K derived: sum of 2 quarters · filed 2023-11-02 | $941.00K 10-Q · filed 2023-11-02 | $1.02M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $364.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $611.00K 10-Q · filed 2023-08-04 | $691.00K derived: sum of 3 quarters · filed 2023-08-04 | $921.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $247.00K 10-Q · filed 2023-05-08 | $327.00K derived: sum of 2 quarters · filed 2023-05-08 | $557.00K derived: sum of 3 quarters · filed 2023-05-08 | $1.77M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $310.00K derived: sum of 2 quarters · filed 2023-03-09 | $1.52M derived: sum of 3 quarters · filed 2023-03-09 | $3.31M 10-K · filed 2023-03-09 |
| 2021-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.44M derived: sum of 2 quarters · filed 2022-11-08 | $3.23M 10-Q · filed 2022-11-08 | $10.72M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.00M 10-Q · filed 2022-08-09 | $10.49M derived: sum of 3 quarters · filed 2022-08-09 | $15.92M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.79M 10-Q · filed 2022-05-09 | $9.28M derived: sum of 2 quarters · filed 2022-08-09 | $14.71M derived: sum of 3 quarters · filed 2022-08-09 | $16.96M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | $7.49M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | $12.91M derived: sum of 2 quarters · filed 2022-08-09 | $15.16M derived: sum of 3 quarters · filed 2022-08-09 | $16.18M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.67M derived: sum of 2 quarters · filed 2021-11-09 | $8.69M 10-Q · filed 2021-11-09 | $8.82M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $3.27M 10-Q · filed 2021-08-10 | $3.40M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $1.02M 10-Q · filed 2021-05-11 | $1.15M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $968.00K 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $840.00K 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |